An Open-Label Randomized Phase II Trial of SAR439859, Versus Endocrine Monotherapy as Per Physician?s Choice in Patients with Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer with Prior Exposure to Hormonal Therapies AMEERA 3

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04059484

Study #:
STUDY00144487

Start Date:
Mar 18, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04059484

View Complete Trial Details & Eligibility at ClinicalTrials.gov